OSR Health, Inc. OSRH
0.23
(0.03)
(11.54%)
as of 25 Sep
- Market cap
- $4.1M
- P/E
- 0.0×
Follow OSRH
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | |
|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | — | — | — | — |
P/S ratio |
3.76 | 7.04 | — | — | — | — |
P/FCF ratio |
0.00 | 0.00 | — | — | — | — |
P/Operating CF |
(10.21) | (137.20) | — | — | — | — |
P/B ratio |
0.09 | 0.17 | — | — | — | — |
Price to Tangible BV |
0.00 | 0.00 | — | — | — | — |
EV/Sales |
4.76 | 7.59 | — | — | — | — |
EV/EBITDA |
0.00 | 0.00 | — | — | — | — |
EV/Operating CF |
(3.19) | (14.49) | — | — | — | — |
EV/FCF |
(2.90) | (14.54) | — | — | — | — |
Quick Ratio |
0.12 | 0.37 | 0.01 | 0.10 | 0.01 | 0.20 |
Current Ratio |
0.16 | 0.67 | 0.01 | 0.10 | 0.01 | 0.20 |
Net Debt/EBITDA |
(0.29) | (0.98) | (0.03) | 3.04 | (1.58) | (9.97) |
Debt/Assets |
2.54% | 1.31% | 0.20% | 1.39% | 1.42% | 92.97% |
Debt/Equity |
0.03 | 0.02 | (0.02) | (0.45) | (4.76) | 250.00 |
Asset Turnover |
0.02 | 0.03 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.16 | 0.18 | (2.03) | 0.12 | 0.15 | 1.00 |
Capex/Depreciation |
(0.07) | 0.00 | — | — | — | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (20.03%) | (14.83%) | (20.48%) | 178.79% | 733.33% | 0.00% | |
| (15.62%) | (9.75%) | 2.13% | (3.67%) | (0.64%) | 0.00% | |
ROIC |
(8.84%) | (5.03%) | 0.00% | 0.00% | (66.53%) | 0.00% |
Return on Tangible Assets |
190.83% | 910.52% | (20.03%) | 3.11% | 0.47% | 9.19% |
Average Days of Receivables |
49.25 | 96.55 | — | — | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | — | — | — | — |
Selling, General and Administrative Expense of Revenue |
651.42% | 354.17% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.98 | 0.98 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | — | — | — | — |
Graham Net Nets |
(3.79) | (1.20) | — | — | — | — |
Graham Number |
0.00 | 0.00 | — | — | — | — |
Earnings Yield |
(228.57%) | (41.57%) | — | — | — | — |
Free Cash Flow Yield |
(43.56%) | (7.42%) | — | — | — | — |
Revenue per Share |
0.15 | 1.64 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.22) | (0.86) | (0.11) | 0.00 | 0.00 | 0.00 |
Capex per Share |
(0.03) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.25) | (0.86) | (0.11) | 0.00 | 0.00 | 0.00 |
Cash per Share |
0.09 | 0.16 | 0.00 | 0.08 | 0.00 | 0.01 |
Shareholders Equity per Share |
6.51 | 66.45 | (0.51) | (0.02) | 0.00 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
6.51 | 66.45 | (0.51) | (0.02) | 0.00 | 0.00 |
Free Cash Flow |
(4.94) | (1.84) | (0.82) | 0.00 | 0.00 | (0.02) |
Working Capital |
(14.35) | (1.14) | (2.02) | (1.14) | (0.70) | (0.26) |
Capital Expenditures |
(0.61) | 0.01 | — | — | — | — |
Net Current Asset Value |
(41.38) | (29.70) | (40.51) | (1.14) | (0.70) | (0.26) |
EV/EBIT |
0.00 | 0.00 | — | — | — | — |
Capex to Sales |
0.21 | 0.00 | — | — | — | — |
Net Profit Margin |
(931.19%) | (292.58%) | 0.00% | 0.00% | 0.00% | 0.00% |
Price to Operating Income |
0.00 | 0.00 | — | — | — | — |
| Other line items | ||||||
Depreciation/Fixed assets |
55.03 | 4,213.04 | — | — | — | — |
Cash ROIC |
(3.38%) | (1.27%) | 21.44% | (4.04%) | (3.94%) | (6.54%) |
Accounts Receivable Turnover |
4.38 | 0.00 | — | — | — | — |
Accounts Payable Turnover |
0.52 | 2.52 | 0.00 | 0.00 | — | — |
Inventory Turnover |
4.14 | 0.00 | — | — | — | — |
Average Days of Payables |
1,235.67 | 144.81 | 0.00 | 0.00 | 0.00 | — |
Days of Inventory on Hand |
30.99 | 123.78 | — | — | — | — |
Average Receivables |
0.66 | — | — | — | — | — |
Average Payables |
4.45 | 1.08 | 0.56 | 0.02 | — | — |
Average Inventory |
0.56 | — | — | — | — | — |
Average Assets |
173.24 | 105.93 | 18.93 | 0.97 | 0.51 | — |
Average Common Equity |
135.12 | 69.65 | (1.97) | (0.02) | 0.00 | — |
Columns are period end dates